Skip to main content
Top
Published in: Internal and Emergency Medicine 6/2017

01-09-2017 | CE - LETTER TO THE EDITOR

Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Comment

Authors: Maria Giulia Tinti, Gaetano Rea, Antonio Mirijello, Elisabetta Frongillo, Marco Sperandeo

Published in: Internal and Emergency Medicine | Issue 6/2017

Login to get access

Excerpt

Dear Editor, …
Literature
2.
go back to reference Reissig A, Gorg C, Mathis G (2009) Transthoracic sonography in the diagnosis of pulmonary diseases: a systematic approach. Ultraschall Med 30:438–454CrossRefPubMed Reissig A, Gorg C, Mathis G (2009) Transthoracic sonography in the diagnosis of pulmonary diseases: a systematic approach. Ultraschall Med 30:438–454CrossRefPubMed
3.
4.
go back to reference Sperandeo M, De Cata A, Molinaro F, Trovato FM, Catalano D, Simeone A, Varriale A, Martines GF (2015) Trovato G ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography. Scand J Rheumatol 44(5):389–398. doi:10.3109/03009742.2015.1011228 CrossRefPubMed Sperandeo M, De Cata A, Molinaro F, Trovato FM, Catalano D, Simeone A, Varriale A, Martines GF (2015) Trovato G ultrasound signs of pulmonary fibrosis in systemic sclerosis as timely indicators for chest computed tomography. Scand J Rheumatol 44(5):389–398. doi:10.​3109/​03009742.​2015.​1011228 CrossRefPubMed
5.
go back to reference Lim HJ, Chung MJ, Shin KE, Hwang HS, Lee KS (2016) The impact of iterative reconstruction in low-dose computed tomography on the evaluation of diffuse interstitial lung disease. Korean J Radiol 17(6):950–960CrossRefPubMedPubMedCentral Lim HJ, Chung MJ, Shin KE, Hwang HS, Lee KS (2016) The impact of iterative reconstruction in low-dose computed tomography on the evaluation of diffuse interstitial lung disease. Korean J Radiol 17(6):950–960CrossRefPubMedPubMedCentral
Metadata
Title
Is there any role for thoracic ultrasound for interstitial lung disease underlying rheumatologic conditions? Comment
Authors
Maria Giulia Tinti
Gaetano Rea
Antonio Mirijello
Elisabetta Frongillo
Marco Sperandeo
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 6/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1663-3

Other articles of this Issue 6/2017

Internal and Emergency Medicine 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.